Skip to content

Depression: all studies

Page 796 of 1,034: studies 7,951 to 7,960 of 10,336, newest first. Back to the depression overview

Research

Clinical effects of mindfulness-based interventions for adults with a history of childhood maltreatment: a scoping review.

Current Treatment Options in Psychiatry June 2021 Diane Joss, Martin H. Teicher

Survivors of childhood maltreatment are at high risk for developing complex psychiatric disorders. Traditional treatments, including psychopharmacology, tend to be less efficacious for this population. This scoping review aimed to discuss existing empirical studies on the effects of mindfulness-based interventions for adult childhood trauma survivors, as well as the documented clinical...

DOI: 10.1007/s40501-021-00240-4 (opens in new tab) Full text (opens in new tab) Early life stress Childhood maltreatment Mind-body interventions Mindful self-compassion msc +1

New drugs in psychiatry - cariprazine, lurasidone, esketamine

Current Problems of Psychiatry June 1, 2021 Kinga Pożarowska, Adam Rusinek, Gracjan Rudziński et al.

Abstract Introduction: Invariably, the search for an “ideal drug” in psychiatry has been going for years, one that is safe and effective, prevents relapse and shows the least possible side effects. Material and methods: The aim of this study authors is to draw attention to new drugs used in psychiatry- cariprazine, lurazidone and esketamine, their mechanism of action, dosage, the most common...

Telephone-guided imagery rehearsal therapy for nightmares: Efficacy and mediator of change.

Journal of Sleep Research June 1, 2021 Jaap Lancee, Marieke Effting, Anna E Kunze

The currently best-supported psychological treatment for nightmares is imagery rehearsal therapy. The problem, however, is that not enough trained practitioners are available to offer this treatment. A possible solution is to conduct imagery rehearsal therapy in a guided self-help format. In the current study, 70 participants with nightmares according to the fifth edition of the Diagnostic and...

DOI: 10.1111/jsr.13123 (opens in new tab) Full text (opens in new tab) Imagery rehearsal treatment Mastery Nightmares Self-help

Death risk: Lack of movement: The ignored pandemic of digitalization escalates the COVID-19 crisis

Technoetic Arts June 1, 2021 Lucas Pawlik

Data analysis from diverse medical fields suggests that we have reached a tipping point in the digitalization dynamic through the ongoing COVID-19 crisis, leading to an escalation of physical inactivity and related diseases. The lack of prioritization of physical activity designed to intervene against obesity, diabetes, loneliness, depression, anxiety disorders and suicide risk could...

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Nature Medicine June 1, 2021 Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein et al. 965 citations

Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with...

DOI: 10.1038/s41591-021-01336-3 (opens in new tab) Full text (opens in new tab) PTSD Treatment MDMA Therapy Clinical trials Mental health breakthrough

Mindfulness-Based Interventions for Physical and Psychological Wellbeing in Cardiovascular Diseases: A Systematic Review and Meta-Analysis

Brain Sciences May 29, 2021 Flavia Marino, Chiara Failla, Cristina Carrozza et al. 54 citations

BACKGROUND: Recently, there has been an increased interest in the efficacy of mindfulness-based interventions (MBI) for people with cardiovascular diseases (CVD), although the exact beneficial effects remain unclear. METHODS: This review aims to establish the role of MBI in the management of wellbeing for patients with CVD. Seventeen articles have been included in this systematic synthesis of...

Psychedelics and health behaviour change

Journal of Psychopharmacology May 29, 2021 Pedro J. Teixeira, Matthew W. Johnson, Christopher Timmermann et al. 87 citations

Healthful behaviours such as maintaining a balanced diet, being physically active and refraining from smoking have major impacts on the risk of developing cancer, diabetes, cardiovascular diseases and other serious conditions. The burden of the so-called ‘lifestyle diseases’—in personal suffering, premature mortality and public health costs—is considerable. Consequently, interventions designed...

The Effects of Mindfulness-Based Mandala Coloring, Made in Nature, on Chronic Widespread Musculoskeletal Pain: Randomized Trial

Healthcare May 28, 2021 Han Choi, Suk-Chan Hahm, Yo-Han Jeon et al.

This study aimed to investigate the effects of mindfulness-based mandala coloring made within nature on individuals with chronic widespread musculoskeletal pain (CWP). Thirty-six participants were randomly allocated. In the experimental group, identical interventions and procedures were administered for each experiment. The control group members were untreated and remained in an urban...

E-mental health mindfulness-based and skills-based ‘CoPE It’ intervention to reduce psychological distress in times of COVID-19: study protocol for a bicentre longitudinal study

BMJ Open May 28, 2021 Florian Junne, Alexander Bäuerle, Martin Teufel et al.

Introduction The SARS-CoV-2 (COVID-19) pandemic poses immense challenges for national and international healthcare systems. Especially in times of social isolation and governmental restrictions, mental health should not be neglected. Innovative approaches are required to support psychologically burdened people. The e-mental health intervention ‘CoPE It’ has been developed to offer manualised...

In Case You Haven't Heard…

Mental Health Weekly May 28, 2021

The use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post‐traumatic stress disorder and other related uses, Financial News Media reported May 25. Some psychedelic drugs are extracted from plants or mushrooms, and some are synthetic (human‐made). These drugs are now considered effective for patients with treatment‐resistant...